Zhifu Sun, MD, MS

  • 4688 Citations
  • 36 Scopus h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Zhifu Sun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Deregulation of long intergenic non-coding RNAs in CD4+ T cells of lamina propria in Crohn's disease through transcriptome profiling

Braga-Neto, M. B., Gaballa, J. M., Bamidele, A. O., Sarmento, O. F., Svingen, P., Gonzalez, M., Ramos, G. P., Sagstetter, M. R., Aseem, S. O., Sun, Z. & Faubion, W. A., Jan 1 2020, In : Journal of Crohn's and Colitis. 14, 1, p. 96-109 14 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19

    Bos, J. M., Hebl, V. B., Oberg, A. L., Sun, Z., Herman, D. S., Teekakirikul, P., Seidman, J. G., Seidman, C. E., dos Remedios, C. G., Maleszewski, J. J., Schaff, H. V., Dearani, J. A., Noseworthy, P. A., Friedman, P. A., Ommen, S. R., Brozovich, F. V. & Ackerman, M. J., Jul 2020, In : Mayo Clinic proceedings. 95, 7, p. 1354-1368 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations

    MCAM abnormal expression and clinical outcome associations are highly cancer dependent as revealed through pan-cancer analysis

    An, Y., Wei, N., Cheng, X., Li, Y., Liu, H., Wang, J., Xu, Z., Sun, Z. & Zhang, X., Mar 23 2020, In : Briefings in bioinformatics. 21, 2, p. 709-718 10 p.

    Research output: Contribution to journalReview article

  • Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis

    Liu, H., Zhang, B. & Sun, Z., Jan 1 2020, In : Cancer Communications. 40, 1, p. 43-59 17 p.

    Research output: Contribution to journalArticle

    Open Access
  • Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway

    Song, Y. A., Ma, T., Zhang, X. Y., Cheng, X. S., Olajuyin, A. M., Sun, Z. D. & Zhang, X. J., May 2 2019, In : Cancer Cell International. 19, 1, 117.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Scopus citations